Medline enters the analysis with 23% upside to the analyst price target and a 3.3-to-1 favorable risk/reward — supported by consecutive earnings beats and a near-perfect Piotroski financial-health score — but heavy reliance on three group-purchasing organizations for approximately 69% of revenues remains the central concentration risk.
Thesis pillars
- Gpo Customer Concentration Risk↑Improving
- Material Upside Favorable Risk Reward↑Improving
- Early Earnings Beat Consistency↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 25, 2026
Medline Inc. (MDLN) Stock Analysis
Falling Knife setup
Healthcare · Medical Instruments & Supplies
Sell if holding. Momentum 1.8/10 is below the 5.0 floor at $32.37 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2).
Medline, founded in 1966, is the largest provider of med-surg products by total net sales, distributing approximately 335,000 products through Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute facilities globally.... Read more
Sell if holding. Momentum 1.8/10 is below the 5.0 floor at $32.37 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2). Chart setup: Death cross, below all MAs, RSI 25, MACD bearish. Score 5.5/10, moderate confidence.
Passes 5/9 gates (favorable risk/reward ratio, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and clean insider activity and death cross (50MA < 200MA) and earnings proximity 6d<=7d. Suitability: moderate.
Recent developments
updated 2026-10-29Recent Developments — Medline Inc.
Latest news
- NEWS Kaplan Fox Initiates Securities Probe into Medline Inc. After FDA Issues Warning on Manufacturing Violations - Kalkine M — Kalkine Media negative
- NEWS Readystate Asset Management LP Invests $10.74 Million in Medline $MDLN - MarketBeat — MarketBeat neutral
- NEWS Medline (MDLN) Q2 2026 Results: Profit Per Share Clears Its Benchmark in Latest Trading - vinanet.vn — vinanet.vn positive
- NEWS Tigress Financial raises Medline stock price target on AI supply chain shift By Investing.com - Investing.com South Afri — Investing.com South Africa positive
- NEWS Tigress Financial raises Medline stock price target on AI supply chain shift - Investing.com Canada — Investing.com Canada positive
Generated 2026-10-29T11:53:51Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerVizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs)69%10-K Item 1A: 'approximately $19.7 billion (or 69% of consolidated net sales ... contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.'
- LOWCustomertop five U.S. customers11%10-K Item 1A: 'our top five U.S. customers represented approximately $3.2 billion (or 11.3%) of our net sales'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 1.8/10 is below the 5.0 floor at $32.37 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2). Chart setup: Death cross, below all MAs, RSI 25, MACD bearish. Prior stop was $31.10. Score 5.5/10, moderate confidence.
Analyst target: $39.88 (+23.2% upside). Prior stop was $31.10. Stop-loss: $31.10.
Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2); Earnings in 6 days (event risk).
Medline Inc. trades at a P/E of 80.9 (forward 20.6). TrendMatrix value score: 6.3/10. Verdict: Sell.
34 analysts cover MDLN with a consensus score of 4.1/5. Average price target: $44.
What does Medline Inc. do?Medline, founded in 1966, is the largest provider of med-surg products by total net sales, distributing approximately...
Medline, founded in 1966, is the largest provider of med-surg products by total net sales, distributing approximately 335,000 products through Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute facilities globally. Prime Vendor agreements generated $18.0 billion (63.4% of net sales) in 2025; the company operates 70 global distribution centers and 2,100+ owned MedTrans trucks, employing over 45,000 people.